Account

Search results for: EU HTA

Reflections on the March 2025 EU HTA Webinar 

On 21 March 2025, the European Commission hosted a public webinar to share updates on the implementa...

Read more
How are countries implementing the EU HTA Regulati...

EU HTA Regulation goes live: A new era for HTA begins  The much-awaited implementation of the r...

Read more
ISPOR Europe 2024: Are companies Ready for the New...

We explore whether pharma and biotech manufacturers are ready for the new EU HTA process and what op...

Read more
ISPOR Europe 2024: Alignment of EU HTA and member ...

We examine whether the joint clinical assessment will expedite patient access and influence value pe...

Read more
Adapting to the EU HTA: how to restructure your Ma...

Our latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...

Read more
EU HTA regulation

Learn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...

Read more
How are local markets adapting their HTA evaluatio...

Our experts analyse how local European markets are integrating the EU HTA outputs into national proc...

Read more
Navigating the new EU HTA regulation: organisation...

Our latest article summarises the key changes to be aware of for the upcoming EU HTA, as well as imp...

Read more
EU HTA: moving from strategy to action

Remap Consulting guides participants through the intricacies of incorporating EU HTA considerations ...

Read more
ISPOR Europe 2023: Can Just Three PICOs be Feasibl...

This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...

Read more
Older

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch